Literature DB >> 19147745

Targeting the apoptosome for cancer therapy.

Elizabeth C Ledgerwood1, Ian M Morison.   

Abstract

Apoptosis is a programmed mechanism of cell death that ensures normal development and tissue homeostasis in metazoans. Avoidance of apoptosis is an important contributor to the survival of tumor cells, and the ability to specifically trigger tumor cell apoptosis is a major goal in cancer treatment. In vertebrates, numerous stress signals engage the intrinsic apoptosis pathway to induce the release of cytochrome c from mitochondria. Cytochrome c binds to apoptosis protease activating factor-1, triggering formation of the apoptosome, a multisubunit protein complex that serves as a platform for caspase activation. In this review we summarize the mechanisms of apoptosome assembly and activation, and our current understanding of the regulation of these processes. We detail the evidence that loss-of-function of the apoptosome pathway may contribute to the development of specific cancers. Finally we discuss recent results showing enhanced sensitivity of some tumor cells to cytochrome c-induced apoptosis, suggesting that agents able to directly or indirectly trigger apoptosome-catalyzed caspase activation in tumor cells could provide new approaches to cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19147745     DOI: 10.1158/1078-0432.CCR-08-1172

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  27 in total

1.  Enhancement of cisplatin-induced apoptosis by β-elemene in resistant human ovarian cancer cells.

Authors:  Qingdi Quentin Li; Rebecca X Lee; Huasheng Liang; Yuhua Zhong; Eddie Reed
Journal:  Med Oncol       Date:  2013-01-01       Impact factor: 3.064

2.  The Apaf-1-binding protein Aven is cleaved by Cathepsin D to unleash its anti-apoptotic potential.

Authors:  I M Melzer; S B M Fernández; S Bösser; K Lohrig; U Lewandrowski; D Wolters; S Kehrloesser; M-L Brezniceanu; A C Theos; P M Irusta; F Impens; K Gevaert; M Zörnig
Journal:  Cell Death Differ       Date:  2012-03-02       Impact factor: 15.828

Review 3.  Mitochondrial and postmitochondrial survival signaling in cancer.

Authors:  Neelu Yadav; Dhyan Chandra
Journal:  Mitochondrion       Date:  2013-12-10       Impact factor: 4.160

4.  BARF1 gene silencing triggers caspase-dependent mitochondrial apoptosis in Epstein-Barr virus-positive malignant cells.

Authors:  Taznim Begam Mohd Mohidin; Ching Ching Ng
Journal:  J Biosci       Date:  2015-03       Impact factor: 1.826

5.  Involvement of ERK1/2/NF-κB signal transduction pathway in TF/FVIIa/PAR2-induced proliferation and migration of colon cancer cell SW620.

Authors:  Donglin Guo; Hong Zhou; Ying Wu; Fang Zhou; Guoying Xu; Haiping Wen; Xianmei Zhang
Journal:  Tumour Biol       Date:  2011-05-28

6.  Phase I Dose-Escalation Study of the Multikinase Inhibitor Lenvatinib in Patients with Advanced Solid Tumors and in an Expanded Cohort of Patients with Melanoma.

Authors:  David S Hong; Razelle Kurzrock; Jennifer J Wheler; Aung Naing; Gerald S Falchook; Siqing Fu; Kevin B Kim; Michael A Davies; Ly M Nguyen; Goldy C George; Lucy Xu; Robert Shumaker; Min Ren; Jennifer Mink; Cynthia Bedell; Corina Andresen; Pallavi Sachdev; James P O'Brien; John Nemunaitis
Journal:  Clin Cancer Res       Date:  2015-07-13       Impact factor: 12.531

7.  Reevesioside F induces potent and efficient anti-proliferative and apoptotic activities through Na⁺/K⁺-ATPase α3 subunit-involved mitochondrial stress and amplification of caspase cascades.

Authors:  She-Hung Chan; Wohn-Jenn Leu; Lih-Ching Hsu; Hsun-Shuo Chang; Tsong-Long Hwang; Ih-Sheng Chen; Ching-Shih Chen; Jih-Hwa Guh
Journal:  Biochem Pharmacol       Date:  2013-10-04       Impact factor: 5.858

8.  TF/FVIIa/PAR2 promotes cell proliferation and migration via PKCα and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620.

Authors:  Lichao Hu; Longfei Xia; Hong Zhou; Biao Wu; Yuan Mu; Ying Wu; Jinchuan Yan
Journal:  Tumour Biol       Date:  2013-04-25

9.  Maximum growth and survival of estrogen receptor-alpha positive breast cancer cells requires the Sin3A transcriptional repressor.

Authors:  Stephanie J Ellison-Zelski; Elaine T Alarid
Journal:  Mol Cancer       Date:  2010-09-29       Impact factor: 27.401

Review 10.  Targeting apoptosis in cancer therapy.

Authors:  Benedito A Carneiro; Wafik S El-Deiry
Journal:  Nat Rev Clin Oncol       Date:  2020-03-23       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.